These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17000335)

  • 41. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
    Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
    Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression?
    Carter JH; Stewart BJ; Lyons KS; Archbold PG
    Mov Disord; 2008 Jul; 23(9):1211-6. PubMed ID: 18528898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ten most commonly asked questions about the psychiatric aspects of Parkinson's disease.
    Reich SG; Marsh L
    Neurologist; 2003 Jan; 9(1):50-6. PubMed ID: 12801432
    [No Abstract]   [Full Text] [Related]  

  • 47. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Behavioral disorders in Parkinson's disease. Genetic, pharmacological and medico-legal aspects].
    Sobrido MJ; Dias-Silva JJ; Quintáns B
    Rev Neurol; 2009 Jan; 48 Suppl 1():S43-8. PubMed ID: 19222015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
    Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
    Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The feasibility of using cognitive behaviour therapy for depression associated with Parkinson's disease: a literature review.
    Cole K; Vaughan FL
    Parkinsonism Relat Disord; 2005 Aug; 11(5):269-76. PubMed ID: 15970452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current developments in Parkinson's disease].
    Guillard A
    Rev Prat; 1986 Mar; 36(17):965-71. PubMed ID: 3704485
    [No Abstract]   [Full Text] [Related]  

  • 52. Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Parkinsonism Relat Disord; 2009 Feb; 15(2):153-5. PubMed ID: 18514013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.
    Martinez-Martin P; Schapira AH; Stocchi F; Sethi K; Odin P; MacPhee G; Brown RG; Naidu Y; Clayton L; Abe K; Tsuboi Y; MacMahon D; Barone P; Rabey M; Bonuccelli U; Forbes A; Breen K; Tluk S; Olanow CW; Thomas S; Rye D; Hand A; Williams AJ; Ondo W; Chaudhuri KR
    Mov Disord; 2007 Aug; 22(11):1623-9. PubMed ID: 17546669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dementia in Parkinson's disease.
    Robottom BJ; Weiner WJ
    Int Rev Neurobiol; 2009; 84():229-44. PubMed ID: 19501721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overview of Parkinson's disease.
    Lew M
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Fraraccio M; Ptito A; Sadikot A; Panisset M; Dagher A
    Arch Clin Neuropsychol; 2008 Jul; 23(4):399-408. PubMed ID: 18394859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.
    Mueller C; Rajkumar AP; Wan YM; Velayudhan L; Ffytche D; Chaudhuri KR; Aarsland D
    CNS Drugs; 2018 Jul; 32(7):621-635. PubMed ID: 30027401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.